Three days after launch, Washington pulled the plug on Claude's two most powerful models.

Run time: 5:38

In today's episode:

1. U.S. government forces Anthropic to disable Fable 5, Mythos 5
2. General chatbots beat dedicated medical AI tools in Nature Medicine
3. SIIM: AI nails the numbers, fumbles the judgment
4. First AI-formulated drug enters a Phase 1 trial
5. Topol: 44 trials, still not standard practice
6. Anthropic credit split and model retirements go live today
7. GPT-5.6 and Gemini 3.5 Pro still stuck in preview

TL;DR:

• Washington issued Anthropic an export-control order three days after launch, forcing it to disable Fable 5 and Mythos 5 for all customers — the model biomedical labs were using for drug design is gone for now.
• A Nature Medicine head-to-head found general-purpose LLMs beat OpenEvidence and UpToDate Expert AI across all three test rounds, with clinicians preferring them; the dedicated tools failed on clarity and safety-critical omissions.
• Radiologists at SIIM 2026 confirmed top LLMs exceed 95% on numerical extraction from scans but still make confident medical-knowledge errors — arithmetic isn't the weak link, judgment is.

Sources cited:

• Nature Medicine
• AuntMinnie
• Contract Pharma
• Medscape
• Ground Truths
• Crescendo AI news roundup
• Anthropic
• Releasebot
• Essa Mamdani

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

An AI just spotted breast cancer in scans taken six years before diagnosis.

Run time: 20:02

In today's episode:

1. AI sees breast cancer six years before diagnosis
2. Stanford crowd cooled on AI scribes after debate
3. Most clinicians admit using unapproved AI tools
4. Saudi hospital shows off practical AI at HLTH Europe
5. States move to regulate AI in insurance approvals
6. Stanford and Mayo read tumors from a blood draw
7. Anthropic splits subscription and API credits June 15
8. xAI's Grok V9 lands mid-June, built on Cursor data
9. Gemini 3.5 Pro still waiting on its June release

TL;DR:

• A Radiology study found three FDA-cleared mammography AIs flagged signs of breast cancer up to six years before diagnosis in about one in five cancers — retrospective, but a big, clean dataset.
• The honest counter-current: Stanford clinicians' support for AI scribes dropped from 69% to 54% after a live debate, and a new survey says ~72% of healthcare staff reach for unapproved "shadow AI" when sanctioned tools fall short.
• Anthropic is splitting subscription and programmatic usage into separate credit pools on June 15 and retiring Opus 4.1 on August 5 — plan your pipelines now.

Sources cited:

• EurekAlert / Radiology
• Stanford Medicine
• Wolters Kluwer
• GlobeNewswire
• Transparency Coalition
• Releasebot
• TechTimes
• TechTimes

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

Anthropic just handed drug labs a model that designs molecules ten times faster.

Run time: 13:30

In today's episode:

1. Ambient AI scribe cuts clinician burnout in randomized trial
2. Philips survey: AI saves sixteen workdays, training lags
3. AIRS SwiftMR wins wider FDA MRI clearance
4. Mount Sinai launches AI cancer trial-matching tool
5. Nature Medicine: AI diagnosis accuracy swings fourfold
6. Topol says every mammogram should use AI
7. Anthropic ships Fable 5, its strongest public model
8. Claude Code adds parallel-subagent dynamic workflows
9. GPT-5.6 and Gemini 3.5 Pro expected this month

TL;DR:

• A pragmatic RCT of an ambient AI scribe cut clinician exhaustion and documentation time without degrading note quality or billing accuracy — the kind of evidence the field keeps promising and rarely delivers.
• Anthropic released Claude Fable 5 (and the unlocked Mythos 5 for vetted bio/security researchers); scientists preferred Mythos 5's molecular-biology hypotheses over Opus-class output ~80% of the time, with a documented ~10x drug-design speedup.
• Philips' Future Health Index says AI already saves clinicians 16 working days a year — while 70% of those same clinicians call their AI training inadequate or nonexistent.

Sources cited:

• NEJM AI
• GlobeNewswire
• Diagnostic Imaging
• Mount Sinai
• Nature Medicine
• Ground Truths
• Anthropic
• Releasebot
• Essa Mamdani
• Primer

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.